Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug-drug Interaction Study Between Bictegravir/Emtricitabine/Tenofovir Alafenamide and Feminizing Hormones in Trans Women Living With HIV

NCT05663892 is registered in ClinicalTrials.gov with Maple Leaf Research as lead sponsor.

NCT NCT05663892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05663892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug-drug Interaction Study Between Bictegravir/Emtricitabine/Tenofovir Alafenamide and Feminizing Hormones in Trans Women Living With HIV
Lead sponsor
Maple Leaf Research
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 23, 2022
Completion date
January 31, 2025
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, transgenderism